Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
236.00
+1.00 (0.43%)
At close: Apr 8, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Other Sales
812.16M----
Pharmaceutical Business Division
62.95B64.74B55.74B50.80B49.70B
Pharmaceutical Business Division Growth
-2.76%16.14%9.74%2.20%9.49%
Bio Business Division
16.87B274.43M---
Bio Business Division Growth
6047.42%----
Game Business Division
357.66M173.22M738.18M2.52B1.20B
Game Business Division Growth
106.48%-76.53%-70.76%110.23%-
Insulation Business Division
6.37B----
Total
87.36B65.19B56.48B53.32B50.90B
Total Growth
34.01%15.42%5.93%4.75%12.13%
Source: S&P Global Market Intelligence.